Go to your personalised cancer information and support area
Learn more about the dashboardExisting Macmillan user? Access your events and volunteering
Members of the Evidence department attended events throughout the year to talk, present or share insights.
The National Cancer Research Institute (NCRI) Conference took place at the Scottish Event Campus in Glasgow on 4-6 November 2018.
It is the UK’s largest conference to showcase advances in cancer research, and provides a platform for researchers, clinicians and industry representatives to discuss and present their latest findings.
As one of 19 partner organisations, Macmillan was delighted to attend the conference to promote how we prioritise, conduct and share our research – which delivers real impact for people living with cancer.
Speakers from the Macmillan sponsored session, including BBC journalist Nick Robinson.
This year, the NCRI created an interdisciplinary programme in five streams:
We sponsored a session on 'The reality of cancer treatment consequences'
Co-chaired by Professor Diana Greenfield, Macmillan Consultant Nurse in Late Effects at Sheffield Teaching Hospital NHS Foundation Trust, and Elspeth Banks from Independent Cancer Patients’ Voice, this session included presentations from high profile speakers.
All of this year's speakers contributed expertise from research, clinical or patient perspectives to help enhance understanding of the late effects of cancer treatment, and how best to inform and support patients.
Nick Robinson from the BBC spoke at the session, drawing on his cancer experience to discuss treatment trade-offs from a patient perspective. Due to the impact of treatment for a lung carcinoid on his vocal chords he had to ‘Learn to live with and embrace uncertainty'. Read the full article on our blog.
We supported the launch of the top 10 UK research priorities in living with and beyond cancer
The NCRI has been working with the James Lind Alliance on a Priority Setting Partnership, bringing together patients, carers and health and social care professionals to understand the most important questions for researchers to answer.
Macmillan proudly partnered in this patient centred approach to determining research priorities, and we intend to focus our next research funding call around them. Further information can be found on the NCRI website and on our blog.
We presented our approach to change in health and social care services with findings from the Improving the Cancer Journey (ICJ) in Glasgow, including:
We asked delegates what research impact means to them, at our stand, and on Twitter using the hashtag #researchimpact
For Macmillan, research impact means the research we fund benefits people affected by cancer by improving treatment and care and empowering people, so it was great to see comments that we are: ‘Creating change’, ‘Changing things for people to improve services and outcomes’ and ‘Supporting better shared decision making’.
Check out our Research Impact Framework for further information.
Betty the MISS bus was onsite throughout the conference, and our MISS team was on hand to answer delegates’ questions on the medical, financial, emotional and practical support we can offer.
CloseWe shared Macmillan-led, joint research and research funded by the Macmillan Research Grants Scheme. This included e-posters, physical posters and presentations on:
Further information about our charity's research and funding partnerships, including our latest research publications and posters, can be found on our website.
In June, members of the Evidence department represented Macmillan at Public Health England’s Cancer Services, Data and Outcomes Conference in Manchester. This annual two-day event allows us to promote how Macmillan is using data, research and evaluations to make an impact and drive improvements in cancer care and support.
The conference attracts prominent members of the cancer data community, researchers, policy makers and clinicians. It provides an important platform to raise Macmillan’s profile as an expert on the 2.5 million people living with cancer in the UK, and the data partnerships we maintain across the UK.
The conference explored how data is being used to prevent, diagnose and help treat people with cancer using research from leading experts, as well as how novel data sets, sources and innovations in the use of cancer data can help make changes to service delivery and quality of patient care.
Macmillan was heavily involved in delivering sessions during the conference, we:
Macmillan-funded researchers also delivered the following programmed sessions:
As always, the event was well attended by members of the cancer data and research community and cancer patients and representatives. For more information on the conference and any downloadable slides, please visit the Public Health England website.
Our research strategy is broadly focussed on, but not limited to, four domains.
Find out about resources, tools and opportunities to support you in your role as a health or social care professional.
In 2018 we supported hundreds of thousands of people with cancer. Our annual report and accounts explain more about how we did this.
What's happening near you? Find out about support groups, where to get information and how to get involved with Macmillan where you are.
Top
© Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 89 Albert Embankment, London SE1 7UQ. VAT no: 668265007
We make every effort to ensure that the information we provide is accurate and up-to-date but it should not be relied upon as a substitute for specialist professional advice tailored to your situation. So far as is permitted by law, Macmillan does not accept liability in relation to the use of any information contained in this publication or third party information or websites included or referred to in it.
